VYLOY is the first and only CLDN18.2-targeted treatment approved in the U.S. for adults with advanced gastric and gastroesophageal junction cancer whose tumors are CLDN18.2 positive TOKYO, Oct. 18 ...
Wausau Pilot & Review A nationwide recall of meat and poultry products potentially contaminated with listeria has expanded to nearly 12 million pounds ...